Xiaowei Dang

732 total citations
33 papers, 509 citations indexed

About

Xiaowei Dang is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Xiaowei Dang has authored 33 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 11 papers in Surgery and 11 papers in Epidemiology. Recurrent topics in Xiaowei Dang's work include Liver Disease and Transplantation (16 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xiaowei Dang is often cited by papers focused on Liver Disease and Transplantation (16 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Liver Disease Diagnosis and Treatment (9 papers). Xiaowei Dang collaborates with scholars based in China, Singapore and Madagascar. Xiaowei Dang's co-authors include Weiwei Wang, Penglei Ge, Yang Wu, Lin Li, Gong Zhang, Zhiqiang Gao, Zhe Tang, Xiu-Xian Ma, Xiaoyu Zhang and Tao Wei and has published in prestigious journals such as Advanced Functional Materials, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Xiaowei Dang

29 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowei Dang China 12 224 165 163 123 95 33 509
Norifumi Iseda Japan 13 171 0.8× 159 1.0× 147 0.9× 180 1.5× 104 1.1× 54 498
Vito Longo Italy 12 284 1.3× 128 0.8× 127 0.8× 94 0.8× 82 0.9× 29 487
Wei Gan China 13 195 0.9× 86 0.5× 123 0.8× 140 1.1× 93 1.0× 32 478
Boyang Chang China 12 224 1.0× 94 0.6× 142 0.9× 76 0.6× 70 0.7× 26 458
Zhixian Hong China 13 194 0.9× 93 0.6× 235 1.4× 119 1.0× 97 1.0× 29 558
Alessio Fabozzi Italy 13 264 1.2× 108 0.7× 221 1.4× 90 0.7× 52 0.5× 32 507
Jin Gu China 11 172 0.8× 85 0.5× 89 0.5× 93 0.8× 80 0.8× 36 412
Petros Fessas United Kingdom 8 341 1.5× 133 0.8× 91 0.6× 64 0.5× 168 1.8× 14 529
Osamu Okochi Japan 9 183 0.8× 72 0.4× 205 1.3× 116 0.9× 125 1.3× 26 518
Francesco Puleo Belgium 11 476 2.1× 151 0.9× 181 1.1× 238 1.9× 104 1.1× 19 668

Countries citing papers authored by Xiaowei Dang

Since Specialization
Citations

This map shows the geographic impact of Xiaowei Dang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Dang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Dang more than expected).

Fields of papers citing papers by Xiaowei Dang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowei Dang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Dang. The network helps show where Xiaowei Dang may publish in the future.

Co-authorship network of co-authors of Xiaowei Dang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowei Dang. A scholar is included among the top collaborators of Xiaowei Dang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowei Dang. Xiaowei Dang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yongjuan, Jingyun Li, Zhiwei Li, et al.. (2025). An ‘AND’ Logic Gate Nanoreactor for Metabolic Remodeling in Starvation‐Ferroptosis‐Immunotherapy of Pancreatic Cancer. Advanced Functional Materials. 35(51).
3.
Li, Yongjuan, Yayun Wang, Xiaohan Lou, et al.. (2024). A polymeric nanoplatform enhances the cGAS-STING pathway in macrophages to potentiate phagocytosis for cancer immunotherapy. Journal of Controlled Release. 373. 447–462. 14 indexed citations
4.
Liu, Chaoqi, Ping Wang, Juan Chang, et al.. (2024). Corn straw-saccharification fiber improved the reproductive performance of sows in the late gestation and lactation via lipid metabolism. Frontiers in Nutrition. 11. 1370975–1370975. 7 indexed citations
5.
Yang, Jing, et al.. (2023). Metformin ameliorates liver fibrosis induced by congestive hepatopathy via the mTOR/HIF-1α signaling pathway. Annals of Hepatology. 28(6). 101135–101135. 8 indexed citations
6.
Yang, Mingfan, Wei Yan, Yan Li, et al.. (2022). The Probiotic Attributes and Anti-pseudorabies Virus Evaluation of Lactobacillus Isolates. Frontiers in Veterinary Science. 9. 902052–902052. 1 indexed citations
7.
Li, Suxin, et al.. (2022). Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma. Frontiers in Immunology. 13. 1076045–1076045. 14 indexed citations
8.
Li, Suxin, Na Huang, Xiaowei Dang, et al.. (2020). A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism. Viral Immunology. 33(2). 112–121. 1 indexed citations
9.
Wang, Hao‐Hao, et al.. (2020). Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy. World Journal of Gastrointestinal Oncology. 12(9). 1031–1043. 11 indexed citations
10.
Dang, Xiaowei, et al.. (2019). Severe hyponatraemia with neurological manifestations in patients treated with terlipressin: Two case reports. Journal of Clinical Pharmacy and Therapeutics. 44(6). 981–984. 2 indexed citations
11.
Ge, Penglei, Weiwei Wang, Lin Li, et al.. (2019). Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer. Biomedicine & Pharmacotherapy. 118. 109228–109228. 172 indexed citations
12.
Wang, Guangyi, et al.. (2019). CD47 blockade alleviates acute rejection of allogeneic mouse liver transplantation by reducing ischemia/reperfusion injury. Biomedicine & Pharmacotherapy. 123. 109793–109793. 13 indexed citations
13.
Wei, Tao, Xiaoyu Zhang, Jiaqi Yang, et al.. (2019). Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer. Cancer Letters. 452. 237–243. 100 indexed citations
14.
Cheng, Wei, Juan Chang, Qingqiang Yin, et al.. (2013). ARTIFICIAL SYNTHESIS OF SWINE HEPCIDIN GENE AND EXPRESSION INPichia pastoris. Preparative Biochemistry & Biotechnology. 44(8). 795–804. 1 indexed citations
15.
Dang, Xiaowei, et al.. (2012). Liver pathology changes in Budd-Chiari syndrome and postnecrotic intrahepatic portal hypertension after shunt surgery. Zhonghua putong waike zazhi. 27(5). 384–387.
16.
Dang, Xiaowei, et al.. (2011). Surgical treatment of Budd-Chiari syndrome: analysis of 221 cases. Hepatobiliary & pancreatic diseases international. 10(4). 435–438. 11 indexed citations
17.
Dang, Xiaowei. (2010). Research Progress on Hepcidin. Anhui nongye kexue. 1 indexed citations
18.
Dang, Xiaowei, et al.. (2006). Study on analgesic characteristics of total alkaloids of paparer mudicaul. Chinese Journal of Hospital Pharmacy. 1 indexed citations
19.
Dang, Xiaowei, et al.. (2005). Splenocaval versus mesocaval shunt with artificial vascular graft for the treatment of Budd-Chiari syndrome.. PubMed. 4(1). 68–70. 1 indexed citations
20.
Dang, Xiaowei, et al.. (2004). Treatment of membranous Budd-Chiari syndrome: analysis of 480 cases.. PubMed. 3(1). 73–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026